Yaelle Tuvy

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

Yelena Y. Janjigian, Francisco Sánchez-Vega, Philip Jonsson et al. · Cancer Discovery · 2017 · 382 citations · Full text

Medicine, Oncology, Immunotherapy +8

<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i> -Amplified Esophagogastric Cancer

Francisco Sánchez-Vega, Jaclyn F. Hechtman, Pau Castel et al. · Cancer Discovery · 2018 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

Megan Greally, Joanne F. Chou, Walid K. Chatila et al. · Clinical Cancer Research · 2019 · 107 citations · Full text

Life Sciences, Immunology, Oncology +17

Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer

Geoffrey Y. Ku, Yelena Kemel, Steve Maron et al. · JAMA Network Open · 2021 · 28 citations · Full text

Medicine, Genetics, Oncology +17

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer

Sebastián Mondaca, Matthew Margolis, Francisco Sánchez-Vega et al. · Gastric Cancer · 2018 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16